iBio, Inc.
NASDAQiBio heads into its May 14 earnings call with a Q3 print already on the table — and the numbers came in slightly softer than hoped. The company reported Q3 fiscal 2026 EPS of -$0.07 overnight on May 12, a penny worse than the -$0.06 consensus estimate. The stock had already lost 25% over the prior month, closing at $1.61 on Tuesday. Despite that slide, the past week was flat…
Snapshot as of 25 Jun 2026
iBio heads into its May 14 earnings call with a Q3 print already on the table — and the numbers came in slightly softer than hoped. The company reported Q3 fiscal 2026 EPS of -$0.07 overnight on May 12, a penny worse…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for IBIO — free to start on ORTEX.
Sign up for free →Open IBIO on ORTEX